×
Back to Agenda
Audits and Agency Inspections of Risk-Based Monitored Studies: The Results Are In...
Session Chair(s)
John Hicks, MBA, MSC
Global Quality Auditing Manager, Eli Lilly and Company, United States
Sponsors, investigator sites, regulators and CRO organizations are invited to share the results of audits and inspections in which risk-based monitoring studies have been assessed.
Learning Objective : Discuss the implementation of the risk-based monitoring approach as judged by auditors and inspectors.
Speaker(s)
Evaluation of Risk-Based Monitoring From the Perspective of the Sponsor’s GCP Auditor
Global Quality Auditing Manager, Eli Lilly and Company, United States
Results from Five Years of Risk-Based Monitoring Studies: Experience with Health Authorities and Internal Auditors
Associate Director, Monitoring Excellence, Bristol-Myers Squibb, United States
Industry Perspective
President and Consultant, Clinical Quality Assured,LLC, United States
Have an account?